Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician's perspective.
Expert review of clinical pharmacology January 1, 2023 Luke J Ney, Wole Akosile, Chris Davey et al. 8 citations
Preclinical and experimental research suggests medicinal cannabis may help treat posttraumatic stress disorder, but integrating it into routine clinical therapies poses clinical, practical, and safety challenges, especially when combined with trauma-focused psychotherapy. Key issues include dose timing and titration, addiction potential, product formulation, windows of intervention, and route of administration. Exposure therapy for PTSD involves recalling intense emotions, and the interaction between cannabis use and reliving trauma memories requires exploration for patient safety and therapeutic outcomes.